Return to homepagePandemic Pact

Development of SARS-CoV-2 Diagnostics

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 75N93023D00018-0-759302400001-1

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2023
    2030

  • Known Financial Commitments (USD)

    $746,197

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    DANA ASHLEY HILL

  • Research Location

    United States of America

  • Lead Research Institution

    RESOURCEPATH, LLC

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

To provide the capacity and capability for a broad range of services necessary for IVD product development support for promising assays and platforms to detect, identify, and characterize human infectious agents.